These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10755058)

  • 1. Effect of acute tryptophan depletion on CO2-induced anxiety in patients with panic disorder and normal volunteers.
    Miller HE; Deakin JF; Anderson IM
    Br J Psychiatry; 2000 Feb; 176():182-8. PubMed ID: 10755058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients.
    Schruers K; Klaassen T; Pols H; Overbeek T; Deutz NE; Griez E
    Psychiatry Res; 2000 Apr; 93(3):179-87. PubMed ID: 10760376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tryptophan depletion and tryptophan loading on the affective response to high-dose CO2 challenge in healthy volunteers.
    Colasanti A; Esquivel G; den Boer E; Horlings A; Dandachi A; Oostwegel JL; van Donkelaar EL; Griez EJ; Schruers K
    Psychopharmacology (Berl); 2011 Jun; 215(4):739-48. PubMed ID: 21336580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute L-5-hydroxytryptophan administration inhibits carbon dioxide-induced panic in panic disorder patients.
    Schruers K; van Diest R; Overbeek T; Griez E
    Psychiatry Res; 2002 Dec; 113(3):237-43. PubMed ID: 12559480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.
    Klaassen T; Klumperbeek J; Deutz NE; van Praag HM; Griez E
    Psychiatry Res; 1998 Feb; 77(3):167-74. PubMed ID: 9707299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT and human anxiety. Evidence from studies using acute tryptophan depletion.
    Anderson IM; Mortimore C
    Adv Exp Med Biol; 1999; 467():43-55. PubMed ID: 10721037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine.
    Mortimore C; Anderson IM
    Psychopharmacology (Berl); 2000 Apr; 149(3):251-8. PubMed ID: 10823406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term prospective evaluation of first-degree relatives of panic patients who underwent the 35% CO2 challenge.
    Perna G; Cocchi S; Allevi L; Bussi R; Bellodi L
    Biol Psychiatry; 1999 Feb; 45(3):365-7. PubMed ID: 10023515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of panic potentiation following 35% CO2 challenge in nonclinical subjects.
    Harrington PJ; Schmidt NB; Telch MJ
    Am J Psychiatry; 1996 Jun; 153(6):823-5. PubMed ID: 8633699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects.
    Papp LA; Martinez JM; Klein DF; Coplan JD; Norman RG; Cole R; de Jesus MJ; Ross D; Goetz R; Gorman JM
    Am J Psychiatry; 1997 Nov; 154(11):1557-65. PubMed ID: 9356564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.
    Tõru I; Shlik J; Maron E; Vasar V; Nutt DJ
    Psychopharmacology (Berl); 2006 May; 186(1):107-12. PubMed ID: 16541242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder.
    Gorman JM; Papp LA; Coplan JD; Martinez JM; Lennon S; Goetz RR; Ross D; Klein DF
    Am J Psychiatry; 1994 Apr; 151(4):547-53. PubMed ID: 8147452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluvoxamine attenuates panic induced by 35% CO2 challenge.
    Pols HJ; Hauzer RC; Meijer JA; Verburg K; Griez EJ
    J Clin Psychiatry; 1996 Nov; 57(11):539-42. PubMed ID: 8968304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of the 35% carbon dioxide panic provocation challenge.
    Verburg K; Pols H; de Leeuw M; Griez E
    Psychiatry Res; 1998 May; 78(3):207-14. PubMed ID: 9657425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alprazolam blockade of CO2-provoked panic in patients with panic disorder.
    Sanderson WC; Wetzler S; Asnis GM
    Am J Psychiatry; 1994 Aug; 151(8):1220-2. PubMed ID: 8037259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.
    Bailey JE; Argyropoulos SV; Kendrick AH; Nutt DJ
    Depress Anxiety; 2005; 21(1):18-25. PubMed ID: 15782425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exercise reduces the effects of a 35% CO2 challenge in patients with panic disorder.
    Esquivel G; Díaz-Galvis J; Schruers K; Berlanga C; Lara-Muñoz C; Griez E
    J Affect Disord; 2008 Apr; 107(1-3):217-20. PubMed ID: 17727960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report.
    Kent JM; Coplan JD; Martinez J; Karmally W; Papp LA; Gorman JM
    Psychiatry Res; 1996 Sep; 64(2):83-90. PubMed ID: 8912949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study.
    Nardi AE; Valença AM; Zin W; Nascimento I
    Arq Neuropsiquiatr; 1999 Jun; 57(2B):361-5. PubMed ID: 10450339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.